These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17659961)

  • 1. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment.
    Weinberger AW; Thiel M; Mohammadi B; Theofylaktopoulos I; Thumann G; Walter P
    Am J Ophthalmol; 2007 Aug; 144(2):294-6. PubMed ID: 17659961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
    Spandau UH; Jonas JB
    Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].
    Kook D; Wolf A; Neubauer AS; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW
    Ophthalmologe; 2008 Feb; 105(2):158-64. PubMed ID: 17653552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Garg S; Brod R; Kim D; Lane RG; Maguire J; Fischer D
    Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
    Carvounis PE; Kopel AC; Benz MS
    Am J Ophthalmol; 2007 Mar; 143(3):504-5. PubMed ID: 17317395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration.
    Chen E; Kaiser RS; Vander JF
    Retina; 2007; 27(4):445-50. PubMed ID: 17420696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
    Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
    Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).
    Nicolò M; Ghiglione D; Calabria G
    Eur J Ophthalmol; 2006; 16(5):770-3. PubMed ID: 17061236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
    Gutfleisch M; Heimes B; Schumacher M; Dietzel M; Lommatzsch A; Bird A; Pauleikhoff D
    Eye (Lond); 2011 Sep; 25(9):1181-6. PubMed ID: 21701525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results.
    Gharbiya M; Allievi F; Recupero V; Martini D; Mazzeo L; Gabrieli CB
    Retina; 2009 Jun; 29(6):740-9. PubMed ID: 19516116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal pigment epithelial tear after intravitreal ranibizumab.
    Bakri SJ; Kitzmann AS
    Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.